SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form EFFECT - Notice of Effectiveness
SEC Accession No. 9999999995-07-001465
Accepted
2007-04-26 00:15:19
Documents
1
Effectiveness Date
2007-04-25
Registration Form
S-1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 597
  Complete submission text file 9999999995-07-001465.txt   2117
Mailing Address 12481 HIGH BLUFF DRIVE, SUITE 160 SAN DIEGO CA 92130
Business Address 12481 HIGH BLUFF DRIVE, SUITE 160 SAN DIEGO CA 92130 (858) 436-8600
Orexigen Therapeutics, Inc. (Filer) CIK: 0001382911 (see all company filings)

IRS No.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-139496 | Film No.: 07789083
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1